China Resources Double-Crane Pharmaceutical Co Ltd
SSE:600062
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
China Resources Double-Crane Pharmaceutical Co Ltd
SSE:600062
|
CN |
|
A
|
Alector Inc
F:0Z2
|
US |
|
CSL Ltd
ASX:CSL
|
AU |
|
CSL Ltd
F:CSJA
|
AU |
|
Rosseti Tsentr I Privolzh'ye PAO
MOEX:MRKP
|
RU |
|
A
|
Aptamer Sciences Inc
KOSDAQ:291650
|
KR |
|
Enterprise Diversified Inc
OTC:ENDI
|
US |
|
C
|
CPI Europe AG
SWB:IMO1
|
AT |
|
CPI Europe AG
F:IMO1
|
AT |
Intrinsic Value
Is China Resources Double-Crane Pharmaceutical Co Ltd undervalued or overvalued?
See the intrinsic value estimate for China Resources Double-Crane Pharmaceutical Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What China Resources Double-Crane Pharmaceutical Does
China Resources Double-Crane Pharmaceutical Co Ltd is a Chinese drug maker that develops, manufactures, and sells medicines for hospitals, pharmacies, and other healthcare channels. Its business is built around prescription drugs, over-the-counter medicines, and related pharmaceutical products, with a mix of branded and generic offerings that serve everyday treatment needs as well as more specialized care.
- Headquarters
- China CN
- Employees
- 13 184
- IPO date
- May 22, 1997
Revenue & Expenses Breakdown
China Resources Double-Crane Pharmaceutical Co Ltd
Earnings Waterfall
China Resources Double-Crane Pharmaceutical Co Ltd
The intrinsic value for China Resources Double-Crane Pharmaceutical Co Ltd (600062) under the Base Case is hidden CNY.
Compared with the current market price of 16.1 CNY, the stock appears hidden.